Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19


A new class of small molecule estrogen receptor-alpha antagonists that overcome anti-estrogen resistance.

Ma Y, Preet A, Tomita Y, De Oliveira E, Zhang L, Ueda Y, Clarke R, Brown M, Rosen EM.

Oncotarget. 2015 Dec 1;6(38):40388-404. doi: 10.18632/oncotarget.6323.


Small-molecule "BRCA1-mimetics" are antagonists of estrogen receptor-α.

Ma Y, Tomita Y, Preet A, Clarke R, Englund E, Grindrod S, Nathan S, De Oliveira E, Brown ML, Rosen EM.

Mol Endocrinol. 2014 Dec;28(12):1971-86. doi: 10.1210/me.2014-1146.


SLC25A1, or CIC, is a novel transcriptional target of mutant p53 and a negative tumor prognostic marker.

Kolukula VK, Sahu G, Wellstein A, Rodriguez OC, Preet A, Iacobazzi V, D'Orazi G, Albanese C, Palmieri F, Avantaggiati ML.

Oncotarget. 2014 Mar 15;5(5):1212-25.


Dissecting the pathways that destabilize mutant p53: the proteasome or autophagy?

Choudhury S, Kolukula VK, Preet A, Albanese C, Avantaggiati ML.

Cell Cycle. 2013 Apr 1;12(7):1022-9. doi: 10.4161/cc.24128. Epub 2013 Mar 6.


Dietary downregulation of mutant p53 levels via glucose restriction: mechanisms and implications for tumor therapy.

Rodriguez OC, Choudhury S, Kolukula V, Vietsch EE, Catania J, Preet A, Reynoso K, Bargonetti J, Wellstein A, Albanese C, Avantaggiati ML.

Cell Cycle. 2012 Dec 1;11(23):4436-46. doi: 10.4161/cc.22778. Epub 2012 Nov 14.


The mitochondrial citrate transporter, CIC, is essential for mitochondrial homeostasis.

Catalina-Rodriguez O, Kolukula VK, Tomita Y, Preet A, Palmieri F, Wellstein A, Byers S, Giaccia AJ, Glasgow E, Albanese C, Avantaggiati ML.

Oncotarget. 2012 Oct;3(10):1220-35.


BRCA1 regulates follistatin function in ovarian cancer and human ovarian surface epithelial cells.

Karve TM, Preet A, Sneed R, Salamanca C, Li X, Xu J, Kumar D, Rosen EM, Saha T.

PLoS One. 2012;7(6):e37697. doi: 10.1371/journal.pone.0037697. Epub 2012 Jun 1.


Tissue and serum microRNAs in the Kras(G12D) transgenic animal model and in patients with pancreatic cancer.

LaConti JJ, Shivapurkar N, Preet A, Deslattes Mays A, Peran I, Kim SE, Marshall JL, Riegel AT, Wellstein A.

PLoS One. 2011;6(6):e20687. doi: 10.1371/journal.pone.0020687. Epub 2011 Jun 27.


Cannabinoid receptors, CB1 and CB2, as novel targets for inhibition of non-small cell lung cancer growth and metastasis.

Preet A, Qamri Z, Nasser MW, Prasad A, Shilo K, Zou X, Groopman JE, Ganju RK.

Cancer Prev Res (Phila). 2011 Jan;4(1):65-75. doi: 10.1158/1940-6207.CAPR-10-0181. Epub 2010 Nov 19.


Epigenetic regulator MLL2 shows altered expression in cancer cell lines and tumors from human breast and colon.

Natarajan TG, Kallakury BV, Sheehan CE, Bartlett MB, Ganesan N, Preet A, Ross JS, FitzGerald KT.

Cancer Cell Int. 2010 Apr 30;10:13. doi: 10.1186/1475-2867-10-13.


Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer.

Qamri Z, Preet A, Nasser MW, Bass CE, Leone G, Barsky SH, Ganju RK.

Mol Cancer Ther. 2009 Nov;8(11):3117-29. doi: 10.1158/1535-7163.MCT-09-0448. Epub 2009 Nov 3.


Slit-2 induces a tumor-suppressive effect by regulating beta-catenin in breast cancer cells.

Prasad A, Paruchuri V, Preet A, Latif F, Ganju RK.

J Biol Chem. 2008 Sep 26;283(39):26624-33. doi: 10.1074/jbc.M800679200. Epub 2008 Jul 8.


Long-term effect of Trigonella foenum graecum and its combination with sodium orthovanadate in preventing histopathological and biochemical abnormalities in diabetic rat ocular tissues.

Preet A, Siddiqui MR, Taha A, Badhai J, Hussain ME, Yadava PK, Baquer NZ.

Mol Cell Biochem. 2006 Sep;289(1-2):137-47. Epub 2006 May 23.


Cannabinoid receptor CB2 modulates the CXCL12/CXCR4-mediated chemotaxis of T lymphocytes.

Ghosh S, Preet A, Groopman JE, Ganju RK.

Mol Immunol. 2006 Jul;43(14):2169-79. Epub 2006 Feb 28.


Immunogenicity of cholera toxin B epitope inserted in Salmonella flagellin expressed on bacteria and administered as DNA vaccine.

Chauhan N, Kumar R, Badhai J, Preet A, Yadava PK.

Mol Cell Biochem. 2005 Aug;276(1-2):1-6.


Supplemental Content

Support Center